Biodegradable nanoparticles for cytosolic delivery of therapeutics

Advanced Drug Delivery Reviews

Volumn 59, Issue 8, 2007, Pages 718-728

  Vasir, Jaspreet K ^a   Labhasetwar, Vinod ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Biodegradable polymers; Cellular uptake; Drug delivery; Endocytosis; Gene delivery; Nanoparticles; Sustained release

Indexed keywords

BIODEGRADABILITY; BIODEGRADABLE POLYMERS; DRUG DELIVERY; GENES; MOLECULAR BIOLOGY;

CELLULAR UPTAKE; CYTOSOLIC DELIVERY; CYTOSOLS; ENDOCYTOSIS; GENE DELIVERY;

NANOPARTICLES;

CELL PENETRATING PEPTIDE; DEXAMETHASONE; DRUG CARRIER; IMMUNOLIPOSOME; MACROGOL; NANOMATERIAL; NANOPARTICLE; POLYGLACTIN; POLYLACTIC ACID; PROTEIN VP22; TRANSACTIVATOR PROTEIN;

CELL MIGRATION; CELL ORGANELLE; CYTOPLASM; CYTOSOL; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG RELEASE; DRUG SOLUBILITY; DRUG TRANSPORT; DRUG UPTAKE; ENDOCYTOSIS; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HYDROPHILICITY; INTERNALIZATION; MOLECULAR MECHANICS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PH MEASUREMENT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW;

ABSORBABLE IMPLANTS; BIOCOMPATIBLE MATERIALS; BIOLOGICAL TRANSPORT; BIOTRANSFORMATION; CHEMISTRY, PHARMACEUTICAL; CYTOSOL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DESIGN; LACTIC ACID; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; POLYMERS;

EID: 34548209237     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2007.06.003     Document Type: Review

References (75)

1. Panyam J., and Labhasetwar V. Targeting intracellular targets. Curr. Drug Deliv. 1 (2004) 235-247
2. Ropert C., Malvy C., and Couvreur P. pH-sensitive liposomes as efficient carriers for intracellular delivery of oligonucleotides. In: Gregoriadis G. (Ed). Strategies for oligonucleotide and gene delivery in therapy (1995), Plenum Press, New York 151-162
3. Collins D. pH-sensitive liposomes as tools for cytoplasmic delivery. In: Philippot J.R., and Schuber F. (Eds). Liposomes as tools in basic research and industry (1995), CRS Press, Boca Raton 201-214
4. Liu D.X., and Huang L. Small, but not large, unilamellar liposomes composed of dioleoylphosphatidylethanolamine and oleic acid can be stabilized by human plasma. Biochemistry 28 (1989) 7700-7707
5. Ellens H., Bentz J., and Szoka F.C. pH-induced destabilization of phosphatidylethanolamine-containing liposomes: role of bilayer contact. Biochemistry 23 (1984) 1532-1538
6. Provoda C.J., Stier E.M., and Lee K.D. Tumor cell killing enabled by listeriolysin O-liposome-mediated delivery of the protein toxin gelonin. J. Biol. Chem. 278 (2003) 35102-35108
7. Mastrobattista E., Koning G.A., van Bloois L., Filipe A.C., Jiskoot W., and Storm G. Functional characterization of an endosome-disruptive peptide and its application in cytosolic delivery of immunoliposome-entrapped proteins. J. Biol. Chem. 277 (2002) 27135-27143
8. Turk M.J., Reddy J.A., Chmielewski J.A., and Low P.S. Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs. Biochim. Biophys. Acta 1559 (2002) 56-68
9. Nir S., Nicol F., and Szoka Jr. F.C. Surface aggregation and membrane penetration by peptides: relation to pore formation and fusion. Mol. Membr. Biol. 16 (1999) 95-101
10. Bailey A.L., Monck M.A., and Cullis P.R. pH-induced destabilization of lipid bilayers by a lipopeptide derived from influenza hemagglutinin. Biochim. Biophys. Acta 1324 (1997) 232-244
11. Chu C.J., Dijkstra J., Lai M.Z., Hong K., and Szoka F.C. Efficiency of cytoplasmic delivery by pH-sensitive liposomes to cells in culture. Pharm. Res. 7 (1990) 824-834
12. Schroit A.J., Madsen J., and Nayar R. Liposome-cell interactions: in vitro discrimination of uptake mechanism and in vivo targeting strategies to mononuclear phagocytes. Chem. Phys. Lipids 40 (1986) 373-393
13. Chu C.J., and Szoka F.C. pH-sensitive liposomes. J. Liposome Res. 4 (1994) 361-395
14. Ho R.J., Rouse B.T., and Huang L. Target-sensitive immunoliposomes: preparation and characterization. Biochemistry 25 (1986) 5500-5506
15. Straubinger R.M., Duzgunes N., and Papahadjopoulos D. pH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules. FEBS Lett. 179 (1985) 148-154
16. Connor J., Norley N., and Huang L. Biodistribution of pH-sensitive immunoliposomes. Biochim. Biophys. Acta 884 (1986) 474-481
17. Simoes S., Moreira J.N., Fonseca C., Duzgunes N., and de Lima M.C. On the formulation of pH-sensitive liposomes with long circulation times. Adv. Drug Deliv. Rev. 56 (2004) 947-965
18. Liu D., and Huang L. Role of cholesterol in the stability of pH-sensitive, large unilamellar liposomes prepared by the detergent-dialysis method. Biochim. Biophys. Acta 981 (1989) 254-260
19. Liu D., and Huang L. pH-sensitive, plasma-stable liposomes with relatively prolonged residence in circulation. Biochim. Biophys. Acta 1022 (1990) 348-354
20. Collins D., Litzinger D.C., and Huang L. Structural and functional comparisons of pH-sensitive liposomes composed of phosphatidylethanolamine and three different diacylsuccinylglycerols. Biochim. Biophys. Acta 1025 (1990) 234-242
21. Liu D., Mori A., and Huang L. Large liposomes containing ganglioside GM1 accumulate effectively in spleen. Biochim. Biophys. Acta 1066 (1991) 159-165
22. Kono K., Igawa T., and Takagishi T. Cytoplasmic delivery of calcein mediated by liposomes modified with a pH-sensitive poly(ethylene glycol) derivative. Biochim. Biophys. Acta 1325 (1997) 143-154
23. Arangoa M.A., Duzgunes N., and Tros de Ilarduya C. Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes. Gene. Ther. 10 (2003) 5-14
24. Fawell S., Seery J., Daikh Y., Moore C., Chen L.L., Pepinsky B., and Barsoum J. Tat-mediated delivery of heterologous proteins into cells. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 664-668
25. Nitin N., Santangelo P.J., Kim G., Nie S., and Bao G. Peptide-linked molecular beacons for efficient delivery and rapid mRNA detection in living cells. Nucleic Acids Res. 32 (2004) e58
26. Ziegler A., Nervi P., Durrenberger M., and Seelig J. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence. Biochemistry 44 (2005) 138-148
27. Wadia J.S., Stan R.V., and Dowdy S.F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10 (2004) 310-315
28. Richard J.P., Melikov K., Vives E., Ramos C., Verbeure B., Gait M.J., Chernomordik L.V., and Lebleu B. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278 (2003) 585-590
29. Alexeyev M.F., Pastukh V.V., Shokolenko I.N., and Wilson G.L. Alpha-complementation-enabled T7 expression vectors and their use for the expression of recombinant polypeptides for protein transduction experiments. Methods Mol. Biol. 267 (2004) 91-100
30. Fotin-Mleczek M., Welte S., Mader O., Duchardt F., Fischer R., Hufnagel H., Scheurich P., and Brock R. Cationic cell-penetrating peptides interfere with TNF signalling by induction of TNF receptor internalization. J. Cell Sci. 118 (2005) 3339-3351
31. Al-Taei S., Penning N.A., Simpson J.C., Futaki S., Takeuchi T., Nakase I., and Jones A.T. Intracellular traffic and fate of protein transduction domains HIV-1 TAT peptide and octaarginine. Implications for their utilization as drug delivery vectors. Bioconjug. Chem. 17 (2006) 90-100
32. Derossi D., Calvet S., Trembleau A., Brunissen A., Chassaing G., and Prochiantz A. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J. Biol. Chem. 271 (1996) 18188-18193
33. Astriab-Fisher A., Sergueev D., Fisher M., Shaw B.R., and Juliano R.L. Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: effects on cellular uptake, binding to target sequences, and biologic actions. Pharm. Res. 19 (2002) 744-754
34. Fischer R., Kohler K., Fotin-Mleczek M., and Brock R. A stepwise dissection of the intracellular fate of cationic cell-penetrating peptides. J. Biol. Chem. 279 (2004) 12625-12635
35. Koul S., Johnson T., Pramanik S., and Koul H. Cellular transfection to deliver alanine-glyoxylate aminotransferase to hepatocytes: a rational gene therapy for primary hyperoxaluria-1 (PH-1). Am. J. Nephrol. 25 (2005) 176-182
36. Dodart J.C., Marr R.A., Koistinaho M., Gregersen B.M., Malkani S., Verma I.M., and Paul S.M. Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1211-1216
37. Qu B., Boyer P.J., Johnston S.A., Hynan L.S., and Rosenberg R.N. Abeta(42) gene vaccination reduces brain amyloid plaque burden in transgenic mice. J. Neurol. Sci. 244 1-2 (2006) 151-158
38. Zhang C., Tang N., Liu X., Liang W., Xu W., and Torchilin V.P. siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene. J. Control. Release 112 2 (2006) 229-239
39. Bengali Z., Pannier A.K., Segura T., Anderson B.C., Jang J.H., Mustoe T.A., and Shea L.D. Gene delivery through cell culture substrate adsorbed DNA complexes. Biotechnol. Bioeng. 90 (2005) 290-302
40. Dincer S., Turk M., and Piskin E. Intelligent polymers as nonviral vectors. Gene Ther. 12 Suppl 1 (2005) S139-S145
41. Rudolph C., Plank C., Lausier J., Schillinger U., Muller R.H., and Rosenecker J. Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. J. Biol. Chem. 278 (2003) 11411-11418
42. Kleemann E., Neu M., Jekel N., Fink L., Schmehl T., Gessler T., Seeger W., and Kissel T. Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI. J. Control. Release 109 (2005) 299-316
43. Rudolph C., Schillinger U., Ortiz A., Tabatt K., Plank C., Muller R.H., and Rosenecker J. Application of novel solid lipid nanoparticle (SLN)-gene vector formulations based on a dimeric HIV-1 TAT-peptide in vitro and in vivo. Pharm. Res. 21 (2004) 1662-1669
44. Zelphati O., Wang Y., Kitada S., Reed J.C., Felgner P.L., and Corbeil J. Intracellular delivery of proteins with a new lipid-mediated delivery system. J. Biol. Chem. 276 (2001) 35103-35110
45. Panyam J., and Labhasetwar V. Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles. Mol. Pharmacol. 1 (2004) 77-84
46. Prabha S., and Labhasetwar V. Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells. Mol. Pharmacol. 1 (2004) 211-219
47. Prabha S., and Labhasetwar V. Critical determinants in PLGA/PLA nanoparticle-mediated gene expression. Pharm. Res. 21 (2004) 354-364
48. Panyam J., and Labhasetwar V. Dynamics of endocytosis and exocytosis of poly(d,l-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm. Res. 20 (2003) 212-220
49. Panyam J., Zhou W.Z., Prabha S., Sahoo S.K., and Labhasetwar V. Rapid endo-lysosomal escape of poly(dl-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. Faseb J 16 (2002) 1217-1226
50. Murakami H., Kobayashi M., Takeuchi H., and Kawashima Y. Preparation of poly(dl-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. Int. J. Pharm. 187 (1999) 143-152
51. Prabha S., Zhou W.Z., Panyam J., and Labhasetwar V. Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. Int. J. Pharm. 244 (2002) 105-115
52. Cohen H., Levy R.J., Gao J., Fishbein I., Kousaev V., Sosnowski S., Slomkowski S., and Golomb G. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Ther. 7 (2000) 1896-1905
53. Tobio M., Nolley J., Guo Y., McIver J., and Alonso M.J. A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle. Pharm. Res. 16 (1999) 682-688
54. Redhead H.M., Davis S.S., and Illum L. Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. J. Control. Release 70 (2001) 353-363
55. Benns J.M., and Kim S.W. Tailoring new gene delivery designs for specific targets. J. Drug Target. 8 (2000) 1-12
56. Otsuka H., Nagasaki Y., and Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv. Drug Deliv. Rev. 55 (2003) 403-419
57. Neal J.C., Stolnik S., Schacht E., Kenawy E.R., Garnett M.C., Davis S.S., and Illum L. In vitro displacement by rat serum of adsorbed radiolabeled poloxamer and poloxamine copolymers from model and biodegradable nanospheres. J. Pharm. Sci. 87 (1998) 1242-1248
58. Stolnik S., Dunn S.E., Garnett M.C., Davies M.C., Coombes A.G., Taylor D.C., Irving M.P., Purkiss S.C., Tadros T.F., Davis S.S., et al. Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers. Pharm. Res. 11 (1994) 1800-1808
59. Hawley A.E., Illum L., and Davis S.S. Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake. Pharm. Res. 14 (1997) 657-661
60. Perez C., Sanchez A., Putnam D., Ting D., Langer R., and Alonso M.J. Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA. J. Control. Release 75 (2001) 211-224
61. Jarver P., and Langel U. The use of cell-penetrating peptides as a tool for gene regulation. Drug Discov. Today 9 (2004) 395-402
62. Torchilin V.P., Rammohan R., Weissig V., and Levchenko T.S. TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 8786-8791
63. Sahoo S.K., and Labhasetwar V. Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol. Pharmacol. 2 (2005) 373-383
64. Sahoo S.K., Ma W., and Labhasetwar V. Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer. Int. J. Cancer 112 (2004) 335-340
65. Wagner E. Application of membrane-active peptides for nonviral gene delivery. Adv. Drug Deliv. Rev. 38 (1999) 279-289
66. Li W., Nicol F., and Szoka Jr. F.C. GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. Adv. Drug Deliv. Rev. 56 (2004) 967-985
67. Wagner E., Plank C., Zatloukal K., Cotten M., and Birnstiel M.L. Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 7934-7938
68. Plank C., Oberhauser B., Mechtler K., Koch C., and Wagner E. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J. Biol. Chem. 269 (1994) 12918-12924
69. Murthy N., Campbell J., Fausto N., Hoffman A.S., and Stayton P.S. Bioinspired pH-responsive polymers for the intracellular delivery of biomolecular drugs. Bioconjug. Chem. 14 (2003) 412-419
70. Subramanian A., Ranganathan P., and Diamond S.L. Nuclear targeting peptide scaffolds for lipofection of nondividing mammalian cells. Nat. Biotechnol. 17 (1999) 873-877
71. Nakanishi M., Akuta T., Nagoshi E., Eguchi A., Mizuguchi H., and Senda T. Nuclear targeting of DNA. Eur. J. Pharm. Sci. 13 (2001) 17-24
72. Gorlich D., and Kutay U. Transport between the cell nucleus and the cytoplasm. Annu. Rev. Cell Dev. Biol. 15 (1999) 607-660
73. Feldherr C.M., and Akin D. The permeability of the nuclear envelope in dividing and nondividing cell cultures. J. Cell Biol. 111 (1990) 1-8
74. Park Y.J., Liang J.F., Ko K.S., Kim S.W., and Yang V.C. Low molecular weight protamine as an efficient and nontoxic gene carrier: in vitro study. J. Gene Med. 5 (2003) 700-711
75. Tkachenko A.G., Xie H., Coleman D., Glomm W., Ryan J., Anderson M.F., Franzen S., and Feldheim D.L. Multifunctional gold nanoparticle-peptide complexes for nuclear targeting. J. Am. Chem. Soc. 125 (2003) 4700-4701